XBI had a nice counter move of gains while the major indexes have rotated out of the AI leaders.

Rare-disease families can now invest in Mahzi Therapeutics' gene therapy, giving patients a financial stake in developing ...

A recovering IPO market, surging mergers and acquisitions fuel more biotech venture deals.

Incyte Corporation is a profitable, cash-generating biotech with a robust pipeline and a core revenue driver in Jakafi. Read ...

Biotech remains one of the market's more out-of-favor sectors despite improving industry fundamentals. Here are three stocks trading near multiyear lows.

The two startups are the third and fourth, respectively, to outline offerings this month and aim to capitalize on momentum ...

Swiss biotech company MindMaze Therapeutics has established its U.S. headquarters at The Pearl innovation district in midtown ...

China’s nascent challenge has U.S. biotech startups hustling to emulate China’s efficiency and speed in drug development.

CNBC’s Jim Cramer pushed viewers away from the usual semiconductor and hyperscaler chatter. Instead, he highlighted a group ...

Discover the best biotech ETFs to diversify your portfolio, gain exposure to cutting-edge biotech innovations, and reduce risk in a volatile sector.

It's been a volatile year for the company, but don't let that scare you away.

Another wave of layoffs has hit one of the Bay Area's biggest biotech companies—and the latest cuts push a troubling trend ...